SHH is a signaling cascade playing a crucial role in cellular proliferation, tissue morphogenic defects and tumor growing [34,122,123,124,125], and is constitutively over-activated by driver mutations in PTCH1 or SMO and by mutations downstream of SMO, involving SUFU, a negative regulator of SHH signaling, and GLI proteins. Here, SMO is linked to neoplasm.